Noam Harpaz, MD

Clinical Focus

• Anal Cancer
• Barrett's Esophagus
• Celiac Disease
• Colon Polyps
• Colorectal Cancer
• Colorectal Resection
• Crohn's Disease
• Diverticulitis
• Esophageal Cancer

Show More

• Anal Cancer
• Barrett's Esophagus
• Celiac Disease
• Colon Polyps
• Colorectal Cancer
• Colorectal Resection
• Crohn's Disease
• Diverticulitis
• Esophageal Cancer
• Esophagectomy
• Gastrectomy
• Gastritis
• Inflammatory Bowel Disease
• Ischemic Bowel Disease
• Peptic Ulcer
• Small Bowel Resection
• Stomach Cancer
• Ulcerative Colitis
• Upper GI Endoscopy

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:54

Article:142

Review Article:14

Comment/Debate:2

Letter:9

Editorial:1

Chapter:2

Recent Artifacts

• Aberrant p53 expression is associated with neoplastic progression in Barrett oesophagus diagnosed as indefinite for dysplasia
• Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia
• Upper Gastrointestinal Manifestations of Inflammatory Bowel Disease
• Luminally polarized mural and vascular remodeling in ileal strictures of Crohn's disease
• High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease
• Magnetic resonance imaging predicts histopathological composition of ileal Crohn's disease
• Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc ^Min/+ mice
• Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease
• Effect of Helicobacter pylori infection on outcomes in resected gastric and gastroesophageal junction cancer
• Serrated lesions in inflammatory bowel disease

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Harpaz during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.